Literature DB >> 14612440

Recombinant human laminin-5 domains. Effects of heterotrimerization, proteolytic processing, and N-glycosylation on alpha3beta1 integrin binding.

Kerstin Künneken1, Gottfried Pohlentz, Alletta Schmidt-Hederich, Uwe Odenthal, Neil Smyth, Jasna Peter-Katalinic, Peter Bruckner, Johannes A Eble.   

Abstract

Human laminin-5 fragments, comprising the heterotrimeric C-terminal part of the coiled-coil (CC) domain and the globular (G) domain with defined numbers of LG subdomains, were produced recombinantly. The alpha3' chain with all five LG subdomains was processed proteolytically in a manner similar to the wild-type alpha3 chain. Conditions were established under which the proteolytic cleavage was either inhibited in cell culture or was brought to completion in vitro. The shorter chains of the laminin-5CCG molecule, beta3'and gamma2', produced in a bacterial expression system associated into heterodimers, which then combined spontaneously with the alpha3' chains in vitro to form heterotrimeric laminin-5CCG molecules. Only heterotrimeric laminin-5CCG with at least subdomains LG1-3, but not the single chains, supported binding of soluble alpha3beta1 integrin, proving the coiled-coil domain of laminin-5 to be essential for its interaction with alpha3beta1 integrin. The N-glycosylation sites in wild-type alpha3 chain were mapped by mass spectrometry. Their location in a structural model of the LG domain suggested that large regions on both faces of the LG1 and LG2 domains are inaccessible by other proteins. However, neither heterotrimerization nor alpha3beta1 integrin binding was affected by the loss of N-linked glycoconjugates. After the proteolytic cleavage between the subdomains LG3 and LG4, the LG4-5 tandem domain dissociated from the rest of the G domain. Further, the laminin-5CCG molecule with the alpha3'LG1-3 chain showed an increased binding affinity for alpha3beta1 integrin, indicating that proteolytic processing of laminin-5 influences its interaction with alpha3beta1 integrin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612440     DOI: 10.1074/jbc.M310424200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Integrin α3β1 as a breast cancer target.

Authors:  Sita Subbaram; C Michael Dipersio
Journal:  Expert Opin Ther Targets       Date:  2011-08-13       Impact factor: 6.902

2.  The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins.

Authors:  Yukimasa Taniguchi; Hiroyuki Ido; Noriko Sanzen; Maria Hayashi; Ryoko Sato-Nishiuchi; Sugiko Futaki; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

3.  Laminin deposition in the extracellular matrix: a complex picture emerges.

Authors:  Kevin J Hamill; Kristina Kligys; Susan B Hopkinson; Jonathan C R Jones
Journal:  J Cell Sci       Date:  2009-12-15       Impact factor: 5.285

4.  Epitope mapping of function-blocking monoclonal antibody CM6 suggests a "weak" integrin binding site on the laminin-332 LG2 domain.

Authors:  Hironobu Yamashita; Meiling Shang; Manisha Tripathi; Jerome Jourquin; Walter Georgescu; Shanshan Liu; Brandy Weidow; Vito Quaranta
Journal:  J Cell Physiol       Date:  2010-06       Impact factor: 6.384

5.  N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.

Authors:  Yoshinobu Kariya; Rika Kato; Satsuki Itoh; Tomohiko Fukuda; Yukinao Shibukawa; Noriko Sanzen; Kiyotoshi Sekiguchi; Yoshinao Wada; Nana Kawasaki; Jianguo Gu
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

6.  Laminin isoforms containing the gamma3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C-terminal regions of the gamma1 and gamma2 chains.

Authors:  Hiroyuki Ido; Shunsuke Ito; Yukimasa Taniguchi; Maria Hayashi; Ryoko Sato-Nishiuchi; Noriko Sanzen; Yoshitaka Hayashi; Sugiko Futaki; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

7.  Why integrin as a primary target for imaging and therapy.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2011       Impact factor: 11.556

8.  Crystal structure of the LG1-3 region of the laminin alpha2 chain.

Authors:  Federico Carafoli; Naomi J Clout; Erhard Hohenester
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

Review 9.  Integrins.

Authors:  Malgorzata Barczyk; Sergio Carracedo; Donald Gullberg
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

Review 10.  Laminin 332 processing impacts cellular behavior.

Authors:  Patricia Rousselle; Konrad Beck
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.